Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.29, $0.27 better than the analyst estimate of $0.02. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $33 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.